Hyliion (HYLN) Financials

Hyliion’s financial statements show a company still in transition, with no clear evidence of a self-sustaining operating business. The company continues to generate most of its revenue from investment interest income and other non-operating sources rather than from product sales. However, quarterly losses and operating cash burn have improved modestly from 2024 and early 2025 levels.

• Quarterly net losses have narrowed. Net loss improved to $11.7 million in Q1 2026 from $17.3 million in Q1 2025 and $15.6 million in Q1 2024. The Q1 2026 loss was also lower than the $13.2 million loss reported in Q4 2025.
• Operating cash burn is moderating. Cash used in operating activities was $12.7 million in Q1 2026, compared with $14.0 million in Q1 2025, $22.7 million in Q1 2024 and $24.5 million in Q4 2023.
• Hyliion maintains a low-debt balance sheet. Total liabilities declined to $9.0 million at March 31, 2026, from $13.0 million at March 31, 2025 and $14.6 million at September 30, 2024. This represents less than 5% of total assets.
• Investment portfolio activity continues to support liquidity. Hyliion generated $25.5 million from investment sales and maturities in Q1 2026, more than offsetting $15.2 million of investment purchases and contributing to $10.1 million of net investing cash inflow.
• Cash remains limited but is supplemented by investments. Cash and equivalents were $20.3 million at the end of Q1 2026, up from $12.3 million a year earlier but below $28.1 million in Q3 2024. The company’s large “other assets” balance suggests that investment holdings remain an important liquidity source, although the data does not provide a detailed breakdown.
• Share count has been relatively stable. Basic weighted-average shares were 177.7 million in Q1 2026 versus 174.3 million in Q1 2025 and 178.5 million in Q1 2024. This limits, but does not eliminate, dilution concerns as the company continues to consume cash.
• Revenue remains small and appears largely non-operating. Q1 2026 revenue was $4.3 million, consisting of $1.5 million of investment interest income and $2.8 million of other non-interest income. Interest income has declined steadily from $3.4 million in Q1 2024, indicating that shrinking or changing investment balances may reduce this support over time.
• Operating expenses continue to overwhelm revenue. Hyliion reported $16.1 million of non-interest expense in Q1 2026, including $7.7 million of marketing expense and $8.8 million of other operating expenses. These costs were nearly four times total revenue, resulting in a $11.7 million pretax and net loss.
• Retained losses continue to erode equity. Retained earnings were negative $218.7 million at March 31, 2026, compared with negative $167.1 million at March 31, 2025 and negative $135.4 million at September 30, 2023. Total assets also fell to $190.8 million from $241.0 million a year earlier, reflecting ongoing capital consumption.
• The company still lacks positive operating cash flow. Despite lower losses, Hyliion has generated negative operating cash flow in every reported quarter included in the data. Continued cash burn means the company may eventually need to reduce spending, liquidate investments or raise capital if operating revenue does not develop.

Overall, Hyliion’s improving loss and cash-burn trends are encouraging, while its low liabilities provide some balance-sheet flexibility. Nevertheless, the company remains dependent on its investment portfolio, has not demonstrated meaningful operating revenue, and continues to incur substantial losses. Investors should focus on whether future quarters show genuine product-related revenue growth and a sustained reduction in operating expenses.